| AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AG Singal, JM Llovet, M Yarchoan, N Mehta, JK Heimbach, LA Dawson, ... Hepatology 78 (6), 1922-1965, 2023 | 717 | 2023 |
| Survival benefit of solid-organ transplant in the United States A Rana, A Gruessner, VG Agopian, Z Khalpey, IB Riaz, B Kaplan, ... JAMA surgery 150 (3), 252-259, 2015 | 523 | 2015 |
| Liver transplantation for “very early” intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment G Sapisochin, M Facciuto, L Rubbia‐Brandt, J Marti, N Mehta, FY Yao, ... Hepatology 64 (4), 1178-1188, 2016 | 346 | 2016 |
| Liver transplantation for nonalcoholic steatohepatitis: the new epidemic VG Agopian, FM Kaldas, JC Hong, M Whittaker, C Holt, A Rana, ... Annals of surgery 256 (4), 624-633, 2012 | 297 | 2012 |
| A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients VG Agopian, M Harlander-Locke, A Zarrinpar, FM Kaldas, DG Farmer, ... Journal of the American College of Surgeons 220 (4), 416-427, 2015 | 265 | 2015 |
| The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center VG Agopian, H Petrowsky, FM Kaldas, A Zarrinpar, DG Farmer, H Yersiz, ... Annals of surgery 258 (3), 409-421, 2013 | 234 | 2013 |
| Liver transplantation in highest acuity recipients: identifying factors to avoid futility H Petrowsky, A Rana, FM Kaldas, A Sharma, JC Hong, VG Agopian, ... Annals of surgery 259 (6), 1186-1194, 2014 | 198 | 2014 |
| Predicting mortality in patients developing recurrent hepatocellular carcinoma after liver transplantation: impact of treatment modality and recurrence characteristics AS Bodzin, KE Lunsford, D Markovic, MP Harlander-Locke, RW Busuttil, ... Annals of surgery 266 (1), 118-125, 2017 | 191 | 2017 |
| Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring N Sun, YT Lee, RY Zhang, R Kao, PC Teng, Y Yang, P Yang, JJ Wang, ... Nature communications 11 (1), 4489, 2020 | 183 | 2020 |
| Impact of pretransplant bridging locoregional therapy for patients with hepatocellular carcinoma within Milan criteria undergoing liver transplantation: analysis of 3601 … VG Agopian, MP Harlander-Locke, RM Ruiz, GB Klintmalm, ... Annals of surgery 266 (3), 525-535, 2017 | 183 | 2017 |
| Evaluation of early allograft function using the liver graft assessment following transplantation risk score model VG Agopian, MP Harlander-Locke, D Markovic, W Dumronggittigule, ... JAMA surgery 153 (5), 436-444, 2018 | 175 | 2018 |
| Blood transfusion requirement during liver transplantation is an important risk factor for mortality A Rana, H Petrowsky, JC Hong, VG Agopian, FM Kaldas, D Farmer, ... Journal of the American College of Surgeons 216 (5), 902-907, 2013 | 170 | 2013 |
| Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform A Zarrinpar, DK Lee, A Silva, N Datta, T Kee, C Eriksen, K Weigle, ... Science translational medicine 8 (333), 333ra49-333ra49, 2016 | 156 | 2016 |
| Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively … VG Agopian, MM Morshedi, J McWilliams, MP Harlander-Locke, ... Annals of surgery 262 (3), 536-545, 2015 | 132 | 2015 |
| Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double‐blind evaluation of 201 donor livers H Yersiz, C Lee, FM Kaldas, JC Hong, A Rana, GT Schnickel, ... Liver Transplantation 19 (4), 437-449, 2013 | 129 | 2013 |
| Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients T Ito, BV Naini, D Markovic, A Aziz, S Younan, M Lu, H Hirao, K Kadono, ... American Journal of Transplantation 21 (2), 614-625, 2021 | 117 | 2021 |
| Ten-year outcomes of liver transplant and downstaging for hepatocellular carcinoma P Tabrizian, ML Holzner, N Mehta, K Halazun, VG Agopian, F Yao, ... JAMA surgery 157 (9), 779-788, 2022 | 116 | 2022 |
| Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10‐year intention‐to‐treat analysis MW Lee, SS Raman, NH Asvadi, S Siripongsakun, RM Hicks, J Chen, ... Hepatology 65 (6), 1979-1990, 2017 | 114 | 2017 |
| Liver transplantation outcomes in a US multicenter cohort of 789 patients with hepatocellular carcinoma presenting beyond Milan criteria A Kardashian, SS Florman, B Haydel, RM Ruiz, GB Klintmalm, DD Lee, ... Hepatology 72 (6), 2014-2028, 2020 | 113 | 2020 |
| 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas F Imani, VG Agopian, MS Auerbach, MA Walter, F Imani, MR Benz, ... Journal of Nuclear Medicine 50 (4), 513-519, 2009 | 111 | 2009 |